Literature DB >> 14652295

Prohibitin 3' untranslated region polymorphism and breast cancer risk.

Ian G Campbell1, James Allen, Diana M Eccles.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14652295

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  7 in total

Review 1.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

2.  Association of 758 G/A polymorphism of 3'untranslated region of prohibitin with risk of gastric cancer.

Authors:  Fenfen Xiang; Zhenhua Ni; Yueping Zhan; Jian Xu; Rong Wu; Xiangdong Kang
Journal:  J Clin Lab Anal       Date:  2017-03-13       Impact factor: 2.352

3.  Prohibitins are required for cancer cell proliferation and adhesion.

Authors:  Claudia Sievers; Gwendolyn Billig; Kathleen Gottschalk; Thomas Rudel
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

4.  Positional and expressive alteration of prohibitin during the induced differentiation of human hepatocarcinoma SMMC-7721 cells.

Authors:  Dong-Hui Xu; Jian Tang; Qi-Fu Li; Song-Lin Shi; Xiang-Feng Chen; Ying Liang
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

5.  Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33.

Authors:  Lucy R Webster; Pamela J Provan; Dinny J Graham; Karen Byth; Robert L Walker; Sean Davis; Elizabeth L Salisbury; Adrienne L Morey; Robyn L Ward; Nicholas J Hawkins; Christine L Clarke; Paul S Meltzer; Rosemary L Balleine
Journal:  Pathology       Date:  2013-12       Impact factor: 5.306

6.  3' untranslated region 1630 C>T polymorphism of prohibitin increases risk of breast cancer.

Authors:  Lin Tang; Yunzhao Zhao; Weiwei Nie; Zexing Wang; Xiaoxiang Guan
Journal:  Onco Targets Ther       Date:  2013-03-09       Impact factor: 4.147

7.  Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism.

Authors:  Anna Jakubowska; Jacek Gronwald; Janusz Menkiszak; Bohdan Górski; Tomasz Huzarski; Tomasz Byrski; Axel Benner; Jan Lubiński; Rodney J Scott; Ute Hamann
Journal:  BMC Cancer       Date:  2008-04-08       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.